Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs CCB for Shoulder Arthroscopy
NCT06913140Completed
- Sponsor
- Tanta University
- Start
- Dec 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Tanta University. Primary endpoint: Total Pethidine consumption at 24 hours. Started Dec 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06913140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06913140.